Huiyu Pharmaceuticals (688553.SH) shareholder Shanghai Shuangsai plans to reduce its shareholding by no more than 2.997%.

Zhtng Cijng APP news, Huiyu Pharmaceutical (688553.SH) announced that, due to its own capital requirements, shareholder Shanghai ShuangSa intends to reduce its holdings of the company's shares by no more than 12.6956 million shares through centralized bidding or block trades, with the total reduction of shares not exceeding 2.997% of the total number of company shares.